Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Molecule Science Foundation Announces Partnership with O'Ryan Health and BlueSavant AI to Advance Autism Research
EIN Presswire
Partnership unites O'Ryan's decentralized data collection with BlueSavant’s Autism AI model with Molecule's community-driven philanthropic funding framework DOVER, DE, UNITED STATES, May 26, 2026 /EINPresswire.com/ -- Molecule Science...
Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions
GlobeNewswire, Inc.
RUTHERFORD, N.J., May 26, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with...
Diasome to Present Phase 2b Results from OPTI-2 Trial Evaluating HDV-Insulin Lispro in Type 1 Diabetes at ADA 86th Scientific Sessions
GlobeNewswire, Inc.
CLEVELAND, May 26, 2026 (GLOBE NEWSWIRE) -- Diasome Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing portal-hepatic targeted therapies for metabolic disease, today announced that results from its OPTI-2 Phase 2b...
Cellular Science to Aesthetics: LIVEYES Wins 2026 MUSE Design Gold
EIN Presswire
U.S. women's wellness brand LIVEYES wins the 2026 MUSE Design Gold Award, merging cellular science with modern aesthetic design.
MetrioPharm AG: Prof. Dr. med. Jürgen Braun Appointed as New Member of the Scientific Advisory Board
GlobeNewswire, Inc.
Prof. Dr. med. Jürgen Braun joins the Scientific Advisory Board of MetrioPharm AG. With more than 800 peer-reviewed publications and various prestigious awards, Prof. Braun is internationally recognized as a leading expert in the field of modern...
AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share
GlobeNewswire, Inc.
PRESS RELEASE FOLLOWING RELEASE OF FYE2025 RESULTS AND SECURING OF CLINICAL TRIAL INSURANCE POLICY, MAXIM GROUP REITERATES ITS BUY RECOMMENDATION ON AB SCIENCE’S STOCK WITH A TARGET PRICE OF EUR 4.0 PER SHARE Paris, May 25, 2026, 6pm CET AB...
GENFIT Highlights Broad Scientific and Strategic Presence at EASL Congress 2026
GlobeNewswire, Inc.
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), May 25, 2026 – GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today...
Nanjing University of Information Science and Technology Study Reveals Evolving Summer Aerosol Pollution
EIN Presswire
Researchers reveal the critical role of secondary species in heavier particulate matter pollution BOSTON, MA, UNITED STATES, May 25, 2026 /EINPresswire.com/ -- Researchers in China studied summer PM1 pollution in Nanjing and found that it is now...
Code of Cultures Probiotics brand’s parent company Fischer Sciences Inc. introduces Women’s Formula Daily Probiotic Supporting Gut & Feminine Wellness in One Capsule
GlobeNewswire, Inc.
VANCOUVER, British Columbia, May 25, 2026 (GLOBE NEWSWIRE) -- Code of Cultures Probiotics’ parent company Fischer Sciences Inc. announced the launch of its new Women's Formula Probiotics, a targeted probiotic supplement formulated to support both...
New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia
GlobeNewswire, Inc.
DUBLIN and BRIDGEWATER, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (Amarin), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today announced new data from a post hoc...
Astrotech Corporation Board of Directors Approves Strategic Lunar Resource and Infrastructure Initiative to Advance Future Moon-Based Quantum Computing Manufacturing
GlobeNewswire, Inc.
AUSTIN, Texas, May 27, 2026 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ: ASTC) ("Astrotech" or the "Company"), a science and technology development company with operational spaceflight heritage, today announced that its Board of Directors...
PerkinElmer Partners with eXXpedition to Advance Ocean Science and a More Sustainable Future
EIN Presswire
SHELTON, CT, UNITED STATES, May 25, 2026 /EINPresswire.com/ -- PerkinElmer, a global leader in analytical solutions that support human and environmental health, today announced a partnership with eXXpedition, the all-women global sailing...
Femtosecond laser direct writing “guiding” Leidenfrost droplet motion
EIN Presswire
FAYETTEVILLE, GA, UNITED STATES, May 27, 2026 /EINPresswire.com/ -- Liquid propulsion on overheated surfaces plays an important role in numerous engineering applications.
Collegium to Participate in 2026 Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
STOUGHTON, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference.
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
GlobeNewswire, Inc.
Conexeu Sciences just 3D-bioprinted a new tissue matrix to one of the most respected regenerative medicine institutes in the world.
BridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9
GlobeNewswire, Inc.
- Accepted for Priority Review with PDUFA target action date of November 27, 2026, and poised to launch upon approval; being granted Priority Review by the FDA reiterates the serious unmet need for treatment options for the LGMD2I/R9 community -...
NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes
GlobeNewswire, Inc.
Pre-IND meeting has been scheduled with FDA to advance type 1 diabetes treatment to First-In-Human clinical trial ZURICH, Switzerland, May 27, 2026 (GLOBE NEWSWIRE) -- NewcelX Ltd. (“NewcelX”; Nasdaq: NCEL), a clinical-stage regenerative medicine...
CDT Announces Canadian Patent for AZD5904 in Male Infertility
GlobeNewswire, Inc.
NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 27, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announces that the patent covering the use of AZD5904 in male infertility has now been granted in Canada,...
HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen
GlobeNewswire, Inc.
Positions the Company to participate in fast-growing, multi-billion-dollar CAR-T immunotherapy market Recently published data suggest that HCW9206 may reduce CAR-T production costs and improve therapeutic efficacies, with the potential to support...
LeonaBio to Participate in Upcoming Medical and Industry Meetings in June
GlobeNewswire, Inc.
BOTHELL, Wash., May 27, 2026 (GLOBE NEWSWIRE) -- LeonaBio, Inc. (NASDAQ: LONA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced that it will...
Sign up for:
Today in Science
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.